Navigation Links
Vaccine patent portfolio licensed from UK Ministry of Defence
Date:2/19/2009

TORONTO, Feb. 19 /PRNewswire/ - Defyrus Inc. today announced the signing an exclusive, worldwide license to a patent portfolio created by the United Kingdom's Defence Science and Technology Laboratory (Dstl) and licensed by Ploughshare Innovation Ltd, Dstl's commercialization company. These patents form the intellectual property foundation of the Company's vaccine product development programs. Defyrus and Ploughshare Innovation Ltd plan to expand their commercial interaction in 2009 to include preclinical safety and efficacy studies as part of the Company's vaccine development program. The commercial terms of the license were not disclosed.

The licensed technology of 27 issued & pending international patents, describes the production of multi-valent vaccines for the treatment of alpha-viral infections resulting from bioterrorism or endemic disease. These highly infectious, mosquito-borne encephalitis viruses pose a serious risk to people and livestock for which no vaccine or therapy exists.

"Dstl has pioneered the investigation of effective medical countermeasures (e.g. vaccines and drugs) for the treatment of a number of important biological diseases that are potential biological warfare threats. Their unique approach to vaccine development and compelling animal efficacy data for viral encephalitis made this license attractive" commented Dr. Jeffrey D. Turner, President & CEO of Defyrus, "We see tremendous synergy in levering investor capital with successful Government R&D programs to drive cost-effective, rapid drug development forward. Improving our capability to respond to viral threats from endemic disease or biological warfare is our mission and represents a significant contribution to protecting the international community from dangerous pathogens".

"Defyrus' business model has the hallmark of a true public-private collaboration. In licensing Dstl's technology to Defyrus, whose management team have a proven track rec
'/>"/>

SOURCE Defyrus Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. DNA vaccine against multiple sclerosis appears safe, potentially beneficial
2. HPV vaccine does not appear to be effective for treating pre-existing HPV infection
3. Vaccine Stops Alzheimers Brain Tangles
4. Human Papilloma Virus vaccines may decrease chances of oral cancer
5. U.S. Teens Fall Short on Vaccine Coverage
6. Nasal Anthrax Vaccine Proves Effective in Animal Study
7. Hot ice, measuring depression, perfect invisibility and flu vaccine incentives
8. Bioniche Receives $2 Million Government Grant For Market Development Related to its E. coli O157:H7 Cattle Vaccine
9. Iomai Patch-Based Vaccine Cut Rate of Travelers Diarrhea by 75 Percent in Phase 2 Field Study
10. FDA approves expanded label for FluMist (influenza virus vaccine live, intranasal) to include childr
11. MedImmune Licenses Reverse Genetics Technology to GlaxoSmithKline for Use in Influenza Vaccine Development and Production
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/18/2013)... University,s scientific pioneersare among the 143 innovators who have ... Inventors. , The distinction is awarded to academics who ... an impact on quality of life, economic development and ... 94 universities and research institutes. Nominated by their peers, ... U.S. patents. , Nobel Laureate Dr. Murad, who ...
(Date:12/18/2013)... Abba Zubair, M.D., Ph.D, believes that cells grown in the ... stroke, and that it may even be possible to generate ... chance to demonstrate the possibility. , He now has it. ... a nonprofit organization that promotes research aboard the ISS, has ... cells into space to see if they grow more rapidly ...
(Date:12/18/2013)... (PRWEB) December 18, 2013 Eliassen ... consulting services firms in the country, is pleased to ... as the director of its IT Staffing and Workforce ... Ranked 19th on Staffing Industry Analysts' list of largest ... with a multitude of private and public-sector clients in ...
(Date:12/18/2013)... In November 2013 at the International Conference on ... Council convened the third meeting of international experts ... accelerate progress toward the Millennium Development Goal of ... access to highly effective, long-acting, reversible contraceptives (LARCs). ... to leadership in increasing access and choice in ...
(Date:12/18/2013)... One of the biggest challenges parents ... mothers with young daughters in today’s overly connected world, ... positive message. Sometimes help is needed to start this ... Keynote Speaker at GiRL Power 2013 , a ... for Women’s Health and Texas Tech University Health Sciences ...
Breaking Medicine News(10 mins):Health News:2 George Washington University researchers named fellows of the National Academy of Inventors 2Health News:Mayo Clinic researcher to grow human cells in space to test treatment for stroke 2Health News:Eliassen Group Promotes Kris Kurcoba to Director of Its Mid-Atlantic Region 2Health News:Long-acting reversible contraception in the context of full access, full choice 2Health News:Long-acting reversible contraception in the context of full access, full choice 3Health News:Long-acting reversible contraception in the context of full access, full choice 4Health News:SBPRA Author Vanessa Pasiadis Featured at Laura W. Bush’s Institute for Women's Health Event 2
... survival rate for those on HAART now equals general ... rates for HIV-infected people lucky enough to get their ... introduction of these drugs in 1996, new British research ... those infected sexually is now about equal to that ...
... online to buy,the new Ion Cell Cleanse foot detox ... detox technology for arthritis, joint pain,removing numerous toxins from ... increasing vital energy, AIDS/HIV, Skin,disorders (Dermatology), Diabetes and more. ... your feet in a tub of warm water for ...
... those close to patient pinpointed who was likely to progress ... new questionnaire may help in both diagnosing older adults facing ... daily living. , The Everyday Cognition instrument consists of 39 ... well. , "There have been a number of studies that ...
... outstanding free clinics receive grants of up to ... effort to address the,growing problem of the uninsured ... (AMA) Foundation has presented 16,outstanding free clinics from ... $25,000., Because of the approximately 46.6 million ...
... lands the insurer on the annual listing for the ... ... Today Black Enterprise magazine,applauded Aflac,s outstanding achievements in workplace ... for Diversity listing.,This recognition highlights the well-branded insurer,s remarkable minority,representation ...
... cut secondhand exposure but also helped current users cut ... -- Smoke-free policies are extremely effective at reducing smoking ... disease, new research shows. , The report, by an ... smoke-free rules don,t affect business in restaurants or bars. ...
Cached Medicine News:Health News:Death Rates for HIV Patients Decrease Dramatically 2Health News:Death Rates for HIV Patients Decrease Dramatically 3Health News:www.IonAvs.com Offers Ionic Foot Detox Baths Worldwide. 2Health News:Mental Test Spots Alzheimer's Risk 2Health News:Mental Test Spots Alzheimer's Risk 3Health News:AMA Foundation Names Healthy Communities/Healthy America Recipients 2Health News:Aflac Named as a Top Company for Diversity by Black Enterprise Magazine 2Health News:Aflac Named as a Top Company for Diversity by Black Enterprise Magazine 3Health News:Smoke-Free Policies Prove Effective 2
(Date:12/18/2013)... WASHINGTON , Dec. 18, 2013 The ... agenda for 2014 to include a new policy priority, ... of new drugs and other forms of treatment that ... or progression-free survival should, at the same time, be ... outcome that affects quality of life—at least as a ...
(Date:12/17/2013)... , Dec. 17, 2013 Halozyme Therapeutics, Inc. (NASDAQ: ... Torley , M.B. Ch. B., M.R.C.P., will be joining ... 6, 2014. She will also become a member of ... Executive Vice President and Chief Commercial Officer at Onyx ... , Ph.D. is departing Halozyme for Intrexon (NYSE: ...
(Date:12/17/2013)... Md. , Dec. 17, 2013  Pharmagen, Inc. ... has executed an agreement with Bagel Boy Equity Group ... Wolpow will become Chairman of the Board of ... work closely with Pharmagen,s CEO, Mackie Barch , ... Company as the platform for deploying a roll-up consolidation ...
Breaking Medicine Technology:New Addition to the Prostate Cancer Roundtable Policy Agenda Addresses Quality-of-Life Endpoints 2New Addition to the Prostate Cancer Roundtable Policy Agenda Addresses Quality-of-Life Endpoints 3Halozyme Therapeutics Announces Executive Transitions 2Halozyme Therapeutics Announces Executive Transitions 3Halozyme Therapeutics Announces Executive Transitions 4Pharmagen Partners with Bagel Boy Equity Group II, LLC and prepares to Launch its Industry Consolidation Strategy 2Pharmagen Partners with Bagel Boy Equity Group II, LLC and prepares to Launch its Industry Consolidation Strategy 3
... 2011 Reportlinker.com announces that a ... in its catalogue: ... Competitive Landscape and Market Forecasts to ... Neurostimulation Devices - ...
... new report criticizes the US Drug Enforcement Administration ... medications without a valid prescription requirement. The ... analyzes the DEA,s implementation of the Ryan Haight Online Pharmacy ... after an 18-year old who died after purchasing Vicodin and ...
Cached Medicine Technology:Reportlinker Adds Neurostimulation Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 2Reportlinker Adds Neurostimulation Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 3Report Criticizes DEA for Failing to Address Online Pharmacy Problem 2
... high-efficiency network for your cardiology department designed ... expandable platform., If your requirements are to:, ... images in real-time (25/30 f/s), Distribute result ... of speed, Connect several cardiac cath labs ...
... Dynamics network is a multimodality, ... system using evidence-based reporting to ... procedures. It has made the ... for hospital echocardiography and ultrasound ...
... interventional cardiology, accurate lesion assessment ... in determining the appropriate stent ... Cardiac 3-D (IC3D), a highly ... clinicians are now able to ...
... Navigation was developed to support innovative, ... is a unique, new method in ... two cutting-edge magnets, physicians are able ... wires through the vessels and chambers ...
Medicine Products: